Assessment of Usability and Satisfaction With a Take-home Device Presenting Sound and Body Stimulation for Back Pain
1 other identifier
interventional
20
1 country
1
Brief Summary
Pain symptoms can have a variety of ways to be treated, from medications to physical therapy, with several options being available to patients. However, no one treatment may work for all people who experience pain, especially cLBP. The purpose of this study is to measure the compliance, usability, and satisfaction of an at-home, multi-modal stimulation device in a diverse population of people with chronic lower back pain (cLBP). The multi-modal device will include a combination of electrical stimulation, auditory stimulation, and integrative-health techniques, including mindfulness breathing, health coaching, and reflective journaling. The multi-modal device creation is based on prior knowledge in lower back pain treatment, which includes electrical stimulation of the back (Transcutaneous Electrical Nerve Stimulator or TENS) and integrative health modalities. In isolation, these treatments are only somewhat effective in reducing symptoms. This pilot study will involve participants who experience cLBP as we investigate a novel at-home, multi-modal device design. The main objective of the pilot usability study is to examine compliance to the intended use of the multi-modal device and approach, as well as protocol feasibility, and satisfaction with the settings and design.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2024
CompletedFirst Submitted
Initial submission to the registry
July 17, 2024
CompletedFirst Posted
Study publicly available on registry
October 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 11, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 11, 2026
August 13, 2025
August 1, 2025
2.1 years
July 17, 2024
August 11, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
compliance rate
Measure compliance in terms of time using the integrative health devices and the multi-modal stimulation device over a period of 12 weeks to determine the effect on participant compliance by adding electrical stimulation to the device.
12 weeks
Secondary Outcomes (1)
satisfaction rate
12 weeks
Study Arms (2)
device group
EXPERIMENTALIntegrative health modality group
ACTIVE COMPARATORInterventions
will be using an FDA- cleared TENS device for electrical stimulation (TENS 7000, Compass Health Brands) in combination with commercially-available headphones for acoustic stimulation (AKG 845 BT).Will be shown how to use the device, trained on the multimodal stimulation procedure, and sent home with the device for 12 weeks.
will be instructed on the integrative health modalities for this study. They will be given a tablet that includes the videos for the visually guided deep breathing. They will also receive the reflective journal and be set up for health coaching visits. At the end of the 12 weeks, this group of participants will return to the U of M campus and complete an interview about satisfaction and usability of the IH modalities.
Eligibility Criteria
You may qualify if:
- Must be 18 years of age or older
- Must be within commuting distance to the University of Minnesota
- Able to provide consent and follow study instructions
- Must be able to understand English
- Must have chronic LBP, which is defined as lower back pain for more than 3 months
- A score of 4 or higher on the PEG
- Must be willing to commit to full duration of the study
- Not currently taking any benzodiazepines or sedative hypnotics
You may not qualify if:
- Back Pain associated with:
- Spondylolisthesis or spinal stenosis
- Sciatica or radiculopathy
- Rhematologic or inflammatory disease
- Trauma, fracture, dislocation, or previous back surgery
- A score of 10 on the PEG
- Pregnant
- Have an electrically implanted device, such as a pacemaker.
- Heart Disease
- Epilepsy
- Cancer
- Psychiatric conditions including psychosis, suicidal ideation, or substance abuse disorder
- A pure tone average of more than 40 dB HL at 500 dB, 1000 dB, or 2000 dB HL.
- Individuals currently using other lower back pain treatments during the study in which they are unable to maintain a steady state while participating in our study for one month before beginning the multi-modal regimen.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Minnesota
Minneapolis, Minnesota, 55414, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Molly Sturges
University of Minnesota
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 17, 2024
First Posted
October 1, 2024
Study Start
July 1, 2024
Primary Completion (Estimated)
August 11, 2026
Study Completion (Estimated)
August 11, 2026
Last Updated
August 13, 2025
Record last verified: 2025-08